BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12063245)

  • 21. The calcineurin activity and MCIP1.4 mRNA levels are increased by innervation in regenerating soleus muscle.
    Fenyvesi R; Rácz G; Wuytack F; Zádor E
    Biochem Biophys Res Commun; 2004 Jul; 320(2):599-605. PubMed ID: 15219871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.
    Fuentes JJ; Genescà L; Kingsbury TJ; Cunningham KW; Pérez-Riba M; Estivill X; de la Luna S
    Hum Mol Genet; 2000 Jul; 9(11):1681-90. PubMed ID: 10861295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Static stretch promotes MEF2A nuclear translocation and expression of neonatal myosin heavy chain in C2C12 myocytes in a calcineurin- and p38-dependent manner.
    Rauch C; Loughna PT
    Am J Physiol Cell Physiol; 2005 Mar; 288(3):C593-605. PubMed ID: 15483225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of moderate acute exercise on expression of mRNA involved in the calcineurin signaling pathway in human skeletal muscle.
    Hitomi Y; Kizaki T; Katsumura T; Mizuno M; Itoh CE; Esaki K; Fujioka Y; Takemasa T; Haga S; Ohno H
    IUBMB Life; 2003 Jul; 55(7):409-13. PubMed ID: 14584592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
    Yao YG; Duh EJ
    Biochem Biophys Res Commun; 2004 Aug; 321(3):648-56. PubMed ID: 15358155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.
    Hesser BA; Liang XH; Camenisch G; Yang S; Lewin DA; Scheller R; Ferrara N; Gerber HP
    Blood; 2004 Jul; 104(1):149-58. PubMed ID: 15016650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylase 3 promotes RCAN1 stability and nuclear translocation.
    Han KA; Kang HS; Lee JW; Yoo L; Im E; Hong A; Lee YJ; Shin WH; Chung KC
    PLoS One; 2014; 9(8):e105416. PubMed ID: 25144594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.
    Gollogly LK; Ryeom SW; Yoon SS
    J Surg Res; 2007 Sep; 142(1):129-36. PubMed ID: 17610901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of calcineurin-NFAT signaling by the pyrazolopyrimidine compound NCI3.
    Sieber M; Karanik M; Brandt C; Blex C; Podtschaske M; Erdmann F; Rost R; Serfling E; Liebscher J; Pätzel M; Radbruch A; Fischer G; Baumgrass R
    Eur J Immunol; 2007 Sep; 37(9):2617-26. PubMed ID: 17694572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase CK2-dependent phosphorylation of the human Regulators of Calcineurin reveals a novel mechanism regulating the calcineurin-NFATc signaling pathway.
    Martínez-Høyer S; Aranguren-Ibáñez A; García-García J; Serrano-Candelas E; Vilardell J; Nunes V; Aguado F; Oliva B; Itarte E; Pérez-Riba M
    Biochim Biophys Acta; 2013 Oct; 1833(10):2311-21. PubMed ID: 23732701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers.
    Oh M; Rybkin II; Copeland V; Czubryt MP; Shelton JM; van Rooij E; Richardson JA; Hill JA; De Windt LJ; Bassel-Duby R; Olson EN; Rothermel BA
    Mol Cell Biol; 2005 Aug; 25(15):6629-38. PubMed ID: 16024798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p38α MAP kinase phosphorylates RCAN1 and regulates its interaction with calcineurin.
    Ma L; Tang H; Ren Y; Deng H; Wu J; Wang Z
    Sci China Life Sci; 2012 Jul; 55(7):559-66. PubMed ID: 22864830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching feedback mechanisms realize the dual role of MCIP in the regulation of calcineurin activity.
    Shin SY; Choo SM; Kim D; Baek SJ; Wolkenhauer O; Cho KH
    FEBS Lett; 2006 Oct; 580(25):5965-73. PubMed ID: 17046757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs.
    Hilioti Z; Gallagher DA; Low-Nam ST; Ramaswamy P; Gajer P; Kingsbury TJ; Birchwood CJ; Levchenko A; Cunningham KW
    Genes Dev; 2004 Jan; 18(1):35-47. PubMed ID: 14701880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators.
    Martínez-Martínez S; Genescà L; Rodríguez A; Raya A; Salichs E; Were F; López-Maderuelo MD; Redondo JM; de la Luna S
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6117-22. PubMed ID: 19332797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway.
    Puri S; Magenheimer BS; Maser RL; Ryan EM; Zien CA; Walker DD; Wallace DP; Hempson SJ; Calvet JP
    J Biol Chem; 2004 Dec; 279(53):55455-64. PubMed ID: 15466861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatic and thermodynamic analysis of calcineurin inhibition by RCAN1.
    Ma Y; Jiang G; Wang Q; Sun Y; Zhao Y; Tong L; Luo J
    Int J Biol Macromol; 2015 Jan; 72():254-60. PubMed ID: 25193101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
    Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
    J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.